Brain Tumours and Inflammatory Markers: Mini-Review
DOI:
https://doi.org/10.31436/imjm.v23i01.2313Keywords:
inflammatory biomarkers, brain tumour, C-reactive protein, interleukin-6, tumour necrosis factor-αAbstract
An inflammatory biomarker is an indicating substance that facilitates the process of cell injury and promotes the development of cancer cells. The brain structure naturally protects the extracellular matrix (ECM), which consists of microglia, astrocytes, and neurons, by separating them from harm with the blood–brain barrier (BBB). Yet, the inflammation process damages the brain cells, thus releasing inflammatory markers into the plasma. Chronic inflammation results from persistent inflammation, and any failure of control mechanisms within the brain tissues will promote the development of cancer cells. Previous studies showed that several proinflammatory biomarkers, which included interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), and C-reactive protein (CRP), were observably higher in patients with glioblastoma compared to those with healthy brain tissues. However, the relationship between proinflammatory factors and glioma development remains unclear. Against such background, this review discusses the potential association between inflammatory markers and a brain tumour, along with the importance of these parameters.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
